Polycystic Ovary Syndrome Drugs Market Segmentation

Global Market Study on Polycystic Ovary
Syndrome (PCOS) Treatment: North America
Likely to Emerge as the Dominant Market in 2016
R e s e a r c h
Report Media Releases
Global Polycystic Ovary Syndrome (PCOS) Drugs Market
to Reach US$ 1,154.8 Mn by 2024; Oral Contraceptives
Drug Class to Witness High Adoption
According to the latest market report published by Persistence Market Research titled ‘Polycystic
Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global
polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the
forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The
M a r k e t
report analyzes the global PCOS drugs market performance and provides information on key
drivers and trends likely to impact the market during the forecast period.
Growth of the global polycystic ovary syndrome drugs market is mainly driven by increasing
prevalence of the disease and a growing awareness among the patient population. Increasing
purchasing power among people and rising awareness of PCOS are factors expected to drive
growth of the global PCOS drugs market. The need for effective management of diseases
associated with PCOS such as hirsutism, obesity, and infertility is likely to boost the demand for
PCOS drugs. Also, a growing popularity of combination drugs and their rising adoption among
the patient population is expected to boost revenue growth of the PCOS drugs market in the
P e r s i s t e n c e
coming years. A rising expenditure on research and development activities and introduction of
novel drugs is further expected to boost growth of the global polycystic ovary syndrome drugs
market over the forecast period. However, lack of FDA approved drugs, a low level of awareness
of PCOS in underdeveloped countries, and increasing side effects associated with generics
might hamper market growth during the forecast period.
Browse Complete Research Study Here @
http://www.persistencemarketresearch.com/market-research/polycystic-ovariansyndrome-drugs-market.asp
The global market for PCOS drugs presents several growth opportunities for market players.
There is a good growth potential in emerging markets and pharmaceutical drugs manufacturers
are focusing on emerging economies in the Asia Pacific and Africa such as Kenya, Nigeria, etc.
to target a large patient population. Also, effective reimbursement policies and reduction in the
costs of drugs used for the treatment of PCOS is likely to increase the adoption of PCOS drugs
Global Polycystic Ovary Syndrome (PCOS) Drugs Market 2016-2024
R e s e a r c h
across the globe. Leading market players are also investing significantly in developing new
branded drugs to treat PCOS, owing to an anticipated high rise in the global patient population.
The demand for branded PCOS drugs is likely to increase significantly during the forecast
period.
Request For Table of Content Here @ http://www.persistencemarketresearch.com/marketresearch/polycystic-ovarian-syndrome-drugs-market/toc
The global PCOS drugs market is segmented based on Drug Class into Oral Contraceptives,
Insulin Sensitizing Agents, Anti-Depressants, Ornithine Decarboxylase Inhibitors, Aromatase
Inhibitors, and Diuretics. The contraceptive drug class segment is projected to register a CAGR
M a r k e t
of 5.4% over the forecast period. Oral contraceptives are generally the preferred first line therapy
for the treatment of PCOS as they are easily available as OTC drugs. The insulin sensitizing
agent segment is expected to register a CAGR of 4.8% over the forecast period. About 70% of
PCOS patients are overweight and are in the category of possible candidates for type 2
diabetes. As a result, insulin sensitizing agents are the widely prescribed drugs for the treatment
of PCOS today. In terms of value, the oral contraceptives and insulin sensitizing agents drug
class segments are collectively expected to remain the dominant and most attractive segments
over the forecast period.
The global PCOS drugs market is segmented based on Distribution Channel into Hospital
Pharmacies, Drug Stores/OTC, E-Commerce, and Fertility Clinics. The hospital pharmacies
P e r s i s t e n c e
segment is likely to lead the global PCOS drugs market in terms of revenue growth and is
estimated to be valued at US$ 575.4 Mn by the end of 2024. In terms of value, the drugs
stores/OTC segment is estimated to account for 27.0% share of the overall market by the end of
2016.
On the basis of region, the market has been segmented into North America, Latin America,
Europe, Asia Pacific, and the MEA. The North America market is expected to emerge as the
dominant market for polycystic ovary syndrome drugs owing to a high diagnosis rate and
increasing adoption of prescription drugs. North America is estimated to dominate the PCOS
drugs market with maximum value share of the overall market by the end of 2016. The presence
of well-established pharmaceutical companies in North America as well as a relatively high
instance of patients being diagnosed in hospitals for PCOS is a major driver for market growth.
The market in the Asia Pacific region is expected to register the highest CAGR of 5.5% over the
forecast period. Significant increase in healthcare services spending along with rapid economic
Global Polycystic Ovary Syndrome (PCOS) Drugs Market 2016-2024
R e s e a r c h
growth and increasing awareness about health issues are some of the key factors likely to push
the sales of PCOS drugs in the APAC market.
Download Research Study Here @
http://www.persistencemarketresearch.com/samples/3682
The report also includes detailed company profiles with company-specific long-term and shortterm strategies, key offerings, and recent developments in the polycystic ovary syndrome
therapeutics market. Some of the leading companies profiled in the report are Sanofi, Novartis,
Teva Pharmaceutical Industries Limited, Addex Therapeutics Ltd., BIOCAD, Merck KGaA, and
AstraZeneca Plc. These companies are primarily focused on enhancing their product portfolio
treatment procedures in order to gain higher market share and to strengthen their respective
position in the global market.
P e r s i s t e n c e
M a r k e t
through research and development activities and the introduction of innovative and cost-effective
Global Polycystic Ovary Syndrome (PCOS) Drugs Market 2016-2024
R e s e a r c h
About Us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
M a r k e t
Our offerings include pre-built reports that address every major sale, customized solutions to
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration research approach for exploring emerging technologies has allowed us to solve the
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and
provide the latest insights into these technologies when they are being commercialized. Our
ground-breaking approach allows us to deliver market solutions before the technologies reach
the market.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing
P e r s i s t e n c e
startups. PMR’s collaborative environment is committed to building industry-specific solutions by
transforming data from multiple streams into a strategic asset.
Contact Us:
Persistence Market Research
90 Sate Street, Suite 700 Albany, NY 12207
Tel: +1-518-618-1030
Email: [email protected]
Website: http://www.persistencemarketresearch.com/
[email protected]
Stay updated with our official Blog: http://pmrblog.com
Global Polycystic Ovary Syndrome (PCOS) Drugs Market 2016-2024

The global PCOS drugs market is segmented based on Drug Class, and Distribution Channel | Polycystic Ovary Syndrome Drugs Market |

Download Report